tiprankstipranks
Trending News
More News >
Shanghai Heartcare Medical Technology Corp. Ltd. Class H (HK:6609)
:6609
Hong Kong Market
Advertisement

Shanghai Heartcare Medical Technology Corp. Ltd. Class H (6609) Stock Forecast & Price Target

Compare
1 Followers
See the Price Targets and Ratings of:

6609 Financial Forecast

6609 Earnings Forecast

The previous quarter’s earnings for 6609 were -HK$0.24.
The previous quarter’s earnings for 6609 were -HK$0.24.

6609 Sales Forecast

The previous quarter’s earnings for 6609 were HK$162.09M.
The previous quarter’s earnings for 6609 were HK$162.09M.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on HK:6609
TipRanks AITipRanks
Not Ranked
TipRanks
HK$47
Hold
-5.72%
Downside
Reiterated
07/17/25
The stock's score is driven primarily by its strong technical momentum, despite its overbought condition. Financial performance shows potential with strong revenue growth and a stable balance sheet, but is offset by profitability and cash flow challenges. The valuation remains weak due to a negative P/E ratio and lack of a dividend yield.
Goldman Sachs Analyst forecast on HK:6609
Chris PanGoldman Sachs
Goldman Sachs
HK$29.8HK$25.6
Buy
-48.65%
Downside
Reiterated
07/19/24
Shanghai HeartCare Medical Technology Corp Ltd (6609:HK) PT Lowered to HK$25.60 at Goldman SachsGoldman Sachs analyst Chris Pan lowered the price target on Shanghai HeartCare Medical Technology Corp Ltd (6609:HK) to HK$25.60 (from HK$29.80) while maintaining a Buy rating.
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on HK:6609
TipRanks AITipRanks
Not Ranked
TipRanks
HK$47
Hold
-5.72%
Downside
Reiterated
07/17/25
The stock's score is driven primarily by its strong technical momentum, despite its overbought condition. Financial performance shows potential with strong revenue growth and a stable balance sheet, but is offset by profitability and cash flow challenges. The valuation remains weak due to a negative P/E ratio and lack of a dividend yield.
Goldman Sachs Analyst forecast on HK:6609
Chris PanGoldman Sachs
Goldman Sachs
HK$29.8HK$25.6
Buy
-48.65%
Downside
Reiterated
07/19/24
Shanghai HeartCare Medical Technology Corp Ltd (6609:HK) PT Lowered to HK$25.60 at Goldman SachsGoldman Sachs analyst Chris Pan lowered the price target on Shanghai HeartCare Medical Technology Corp Ltd (6609:HK) to HK$25.60 (from HK$29.80) while maintaining a Buy rating.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Shanghai Heartcare Medical Technology Corp. Ltd. Class H

1 Month
xxx
Success Rate
0/2 ratings generated profit
0%
Average Return
-1.90%
reiterated a xxx
rating a year ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 0.00% of your transactions generating a profit, with an average return of -1.90% per trade.
3 Months
xxx
Success Rate
1/2 ratings generated profit
50%
Average Return
+8.45%
reiterated a xxx
rating a year ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +8.45% per trade.
1 Year
Chris PanGoldman Sachs
Success Rate
2/2 ratings generated profit
100%
Average Return
+119.95%
reiterated a buy rating a year ago
Copying Chris Pan's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +119.95% per trade.
2 Years
xxx
Success Rate
2/2 ratings generated profit
100%
Average Return
+161.50%
reiterated a xxx
rating a year ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +161.50% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

6609 Analyst Recommendation Trends

Rating
Apr 24
Jul 24
May 25
Jun 25
Jul 25
Strong Buy
1
2
2
1
0
Buy
0
0
0
0
0
Hold
2
2
2
5
10
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
3
4
4
6
10
In the current month, 6609 has received 0 Buy Ratings, 10 Hold Ratings, and 0 Sell Ratings. 6609 average Analyst price target in the past 3 months is 39.00.
Each month's total comprises the sum of three months' worth of ratings.

6609 Stock Forecast FAQ

What is HK:6609’s average 12-month price target, according to analysts?
Based on analyst ratings, Shanghai Heartcare Medical Technology Corp. Ltd. Class H’s 12-month average price target is 39.00.
    What is HK:6609’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for HK:6609, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is Shanghai Heartcare Medical Technology Corp. Ltd. Class H a Buy, Sell or Hold?
        Shanghai Heartcare Medical Technology Corp. Ltd. Class H has a consensus rating of Hold, which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
          What is Shanghai Heartcare Medical Technology Corp. Ltd. Class H’s share price target?
          The average share price target for Shanghai Heartcare Medical Technology Corp. Ltd. Class H is 39.00. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is HK$39.00 ,and the lowest forecast is HK$39.00. The average share price target represents -21.77% Decrease from the current price of HK$49.85.
            What do analysts say about Shanghai Heartcare Medical Technology Corp. Ltd. Class H?
            Shanghai Heartcare Medical Technology Corp. Ltd. Class H’s analyst rating consensus is a Hold. This is based on the ratings of 0 Wall Streets Analysts.
              How can I buy shares of Shanghai Heartcare Medical Technology Corp. Ltd. Class H?
              To buy shares of HK:6609, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis